华东医药
(000963)
| 流通市值：483.83亿 | | | 总市值：484.03亿 |
| 流通股本：17.53亿 | | | 总股本：17.54亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,114,658,586.14 | 5,605,360,468.39 | 3,734,865,777.19 | 4,978,052,188.84 |
| 应收票据及应收账款 | 10,671,374,376.01 | 8,850,825,667.24 | 11,076,591,135.34 | 8,991,801,339.36 |
| 其中：应收票据 | - | 9,420,826.08 | - | 6,213,394.05 |
| 应收账款 | 10,671,374,376.01 | 8,841,404,841.16 | 11,076,591,135.34 | 8,985,587,945.31 |
| 应收款项融资 | 275,990,595.36 | 865,267,156.65 | 332,387,014.92 | 460,578,206.16 |
| 预付款项 | 568,274,574.69 | 440,117,285.4 | 508,155,787.14 | 445,803,941.09 |
| 其他应收款合计 | 661,294,700.98 | 632,928,610.62 | 609,897,223.8 | 517,535,129.39 |
| 应收股利 | 2,623,608.84 | 5,024,474.67 | 223,608.84 | 223,608.84 |
| 存货 | 5,247,188,765.3 | 5,030,683,149.6 | 5,327,579,147.01 | 5,535,765,919.86 |
| 一年内到期的非流动资产 | - | - | 75,464,880.54 | 75,464,880.54 |
| 其他流动资产 | 62,933,844.61 | 188,965,311.55 | 139,274,907.01 | 222,343,329.23 |
| 流动资产合计 | 21,601,715,443.09 | 21,614,147,649.45 | 21,804,215,872.95 | 21,227,344,934.47 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,656,251,583.79 | 1,650,742,294.8 | 1,629,415,091.83 | 1,509,122,017.22 |
| 其他权益工具投资 | 671,448,183.43 | 674,265,706.81 | 682,132,315.02 | 681,006,253.76 |
| 投资性房地产 | 10,265,840.53 | 10,480,170.79 | 10,694,501.05 | 10,946,776.47 |
| 固定资产 | 4,204,722,172.53 | 4,289,689,684.93 | 4,389,958,201.12 | 4,470,264,264.88 |
| 在建工程 | 1,069,086,051.99 | 987,615,685.14 | 931,509,517.77 | 832,431,516.18 |
| 使用权资产 | 165,750,550.91 | 199,999,619.57 | 158,409,996.23 | 170,395,474.59 |
| 无形资产 | 3,696,210,279.5 | 3,798,710,511.5 | 3,922,211,412.97 | 3,849,691,624.59 |
| 开发支出 | 2,308,368,923.41 | 2,119,595,539.5 | 1,943,582,627.6 | 1,757,196,902.53 |
| 商誉 | 2,839,760,558.34 | 2,839,831,632.3 | 2,848,210,102.92 | 2,860,135,566.37 |
| 长期待摊费用 | 15,319,401.29 | 16,458,438.84 | 18,776,159.14 | 19,541,767.43 |
| 递延所得税资产 | 439,471,541.59 | 439,471,542.07 | 385,084,524.44 | 385,084,524.45 |
| 其他非流动资产 | 1,398,586,567.51 | 1,334,473,280.11 | 1,183,842,241.9 | 1,264,874,697.98 |
| 非流动资产合计 | 18,475,241,654.82 | 18,361,334,106.36 | 18,103,826,691.99 | 17,810,691,386.45 |
| 资产总计 | 40,076,957,097.91 | 39,975,481,755.81 | 39,908,042,564.94 | 39,038,036,320.92 |
| 流动负债: | | | | |
| 短期借款 | 1,644,031,190.59 | 1,715,030,135.18 | 1,714,508,902.52 | 1,621,903,523.77 |
| 应付票据及应付账款 | 8,345,727,447.62 | 8,312,396,351.72 | 7,609,567,039.98 | 7,969,901,859.1 |
| 其中：应付票据 | 3,593,991,987.15 | 3,068,414,627.61 | 3,017,614,936.17 | 2,910,051,094.08 |
| 应付账款 | 4,751,735,460.47 | 5,243,981,724.11 | 4,591,952,103.81 | 5,059,850,765.02 |
| 预收款项 | 378,380.95 | 495,915.58 | 502,191.65 | 797,358.84 |
| 合同负债 | 164,775,321.86 | 145,747,142.69 | 232,364,085.08 | 188,554,462.61 |
| 应付职工薪酬 | 204,968,164.89 | 212,037,322.11 | 237,138,507.68 | 411,598,841.94 |
| 应交税费 | 371,864,924.42 | 373,250,286.43 | 553,756,331.7 | 563,317,023.92 |
| 其他应付款合计 | 2,434,462,401.22 | 2,581,603,873.52 | 2,567,376,516.56 | 2,215,275,211.55 |
| 应付股利 | 71,810,219.6 | 101,810,219.6 | 101,810,219.6 | 102,560,219.6 |
| 一年内到期的非流动负债 | 69,732,665.49 | 72,199,920.12 | 82,978,800.49 | 108,871,732.55 |
| 其他流动负债 | 19,497,331.32 | 17,003,618.72 | 34,942,891.8 | 10,443,641.94 |
| 流动负债合计 | 13,255,437,828.36 | 13,429,764,566.07 | 13,033,135,267.46 | 13,090,663,656.22 |
| 非流动负债: | | | | |
| 长期借款 | 251,325,999.47 | 250,096,486.73 | 251,619,962.82 | 252,034,854.55 |
| 租赁负债 | 109,385,827.42 | 116,993,386.72 | 111,057,382.92 | 88,813,504.2 |
| 预计负债 | 3,835,777.67 | 4,018,799.32 | 19,922,759.61 | 20,617,015.41 |
| 递延收益 | 177,622,471.78 | 182,119,801.26 | 187,359,036.43 | 190,942,291.61 |
| 递延所得税负债 | 207,476,893.39 | 212,327,829.99 | 217,236,393.17 | 223,959,318.75 |
| 非流动负债合计 | 749,646,969.73 | 765,556,304.02 | 787,195,534.95 | 776,366,984.52 |
| 负债合计 | 14,005,084,798.09 | 14,195,320,870.09 | 13,820,330,802.41 | 13,867,030,640.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,753,736,848 | 1,753,736,848 | 1,753,736,848 | 1,753,736,848 |
| 资本公积 | 2,404,947,289.65 | 2,405,166,419.87 | 2,416,510,921.2 | 2,416,358,618.64 |
| 其他综合收益 | -184,723,509.39 | -194,461,639.77 | -74,836,933.54 | 5,770,687.07 |
| 盈余公积 | 1,616,443,486.39 | 1,616,443,486.39 | 1,616,443,486.39 | 1,616,443,486.39 |
| 未分配利润 | 20,159,466,419.9 | 19,860,477,809.2 | 20,021,219,710.05 | 19,019,030,352.89 |
| 归属于母公司股东权益合计 | 25,749,870,534.55 | 25,441,362,923.69 | 25,733,074,032.1 | 24,811,339,992.99 |
| 少数股东权益 | 322,001,765.27 | 338,797,962.03 | 354,637,730.43 | 359,665,687.19 |
| 股东权益合计 | 26,071,872,299.82 | 25,780,160,885.72 | 26,087,711,762.53 | 25,171,005,680.18 |
| 负债和股东权益合计 | 40,076,957,097.91 | 39,975,481,755.81 | 39,908,042,564.94 | 39,038,036,320.92 |
| 公告日期 | 2026-10-29 | 2026-08-27 | 2026-04-24 | 2026-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |